BD Nexiva



The BD Nexiva™ Closed IV Catheter System is the only integrated IV catheter with two recently published randomized controlled trials demonstrating longer dwell times and reduced complication rates vs the traditional open system.

The BD Nexiva™ Diffusics™ Closed IV Catheter System is designed to address common computed tomography (CT) IV challenges during power injection procedures.

download brochure




The BD Nexiva™ Closed IV Catheter System:

Seamless Patient Care, with an IV Catheter that Lasts

Any disruption in the treatment process can affect your ability to provide quality care and can negatively impact the patient experience. That’s why the BD Nexiva™ Closed IV Catheter System, the first of its kind, all-in-one closed system IV catheter, is designed to minimize the risk of IV catheter failure.1

  • Catheter’s stabilization platform* minimizes movement that can lead to catheter complications, restarts and associated costs2†
    • Built-in stabilization platform and pre-attached extension tubing
    • Reduces dislodgement by 84%
    • Meets the INS Standards and CDC Guidelines for catheter stabilization1,3
  • Proprietary BD Vialon™ Biomaterial enables longer dwell times,4‡ supporting the current Infusion Nursing Standards of Practice for clinically indicated site rotation3
    • In a 2014 clinical study, it was demonstrated that BD Nexiva™ catheters had a low rate of phlebitis and a median dwell time of 144 hours for catheters in place ≥ 24 hours
    • In a 2014 clinical study, the longer dwell times of closed systems led to a cost reduction of approximately $1M/year/1,000 beds compared to an system5
  • Designed to minimize treatment delays and complications
    • Power injection compatible, minimizing the need to exchange catheter or tubing
    • Single and dual ports and 18- to 22-gauge bore tubing are indicated for use in CT power injection
    • Avoid leaking at the catheter/extension set connection due to the integrated system
  • Integrated systems need fewer add-on devices, minimizing the number of manipulations which may lead to touch contamination and accidental disconnections3,6**
  • BD Instaflash™ Needle Technology quick blood visualization may help improve insertion success, and therefore reduce insertion attempts
  • BD Vialon™ Biomaterial has been clinically demonstrated to dwell up to 144 hours5